- Home
- EMA vs BAX Comparison
EMA vs BAX Comparison
Compare EMA & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EMA | BAX |
|---|---|---|
| Founded | 1998 | 1931 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.3B | 9.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | EMA | BAX |
|---|---|---|
| Price | $47.48 | $18.54 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $25.67 |
| AVG Volume (30 Days) | 190.9K | ★ 8.3M |
| Earning Date | 11-07-2025 | 10-30-2025 |
| Dividend Yield | ★ 4.38% | 0.22% |
| EPS Growth | ★ 67.89 | N/A |
| EPS | ★ 2.65 | N/A |
| Revenue | $6,126,111,896.00 | ★ $11,023,000,000.00 |
| Revenue This Year | $24.94 | $5.20 |
| Revenue Next Year | N/A | $2.02 |
| P/E Ratio | $18.04 | ★ N/A |
| Revenue Growth | ★ 15.17 | 3.90 |
| 52 Week Low | $35.64 | $17.40 |
| 52 Week High | $49.77 | $37.74 |
Technical Indicators
Market Signals| Indicator | EMA | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 43.14 | 43.20 |
| Support Level | $47.03 | $18.33 |
| Resistance Level | $48.91 | $19.17 |
| Average True Range (ATR) | 0.70 | 0.54 |
| MACD | -0.08 | 0.21 |
| Stochastic Oscillator | 19.15 | 63.23 |
Price Performance
Historical ComparisonAbout EMA Emera Incorporated Common Shares
Emera is a geographically diverse energy and services company investing in electricity generation, transmission, and distribution as well as gas transmission and utility energy services. Emera has operations throughout North America and the Caribbean countries.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.